Urological Malignancies Clinical Trial
Official title:
A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis
PET CT is one of the imaging tools that are used for staging of urological malignancies.
C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine.
This advantage makes it a potentially better metabolic marker then others such as FDG.
Preliminary studies showed ~95% sensitivity in the diagnosis of TCC. Our Goal is to continue
the evaluation of this method as a diagnostic and follow up tool in different urological
malignancies.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04625556 -
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
|